3.0.0 1276 2023-01-11T13:36:22Z 2023-01-11T13:36:22Z Senate S 2017-05-25 115 ssju00 Judiciary Committee Senate Standing Referred to 2017-05-25T20:17:07Z 2017-05-25 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S3220-3221) IntroReferral 2017-05-25 Introduced in Senate IntroReferral 10000 9 Library of Congress F000062 Sen. Feinstein, Dianne [D-CA] Dianne Feinstein D CA N G000386 Sen. Grassley, Chuck [R-IA] Charles Grassley R IA E. 2017-05-25 True D000563 Sen. Durbin, Richard J. [D-IL] Richard Durbin D IL J. 2017-05-25 True T000476 Sen. Tillis, Thomas [R-NC] Thomas Tillis R NC Roland 2017-05-25 True E000295 Sen. Ernst, Joni [R-IA] Joni Ernst R IA 2017-05-25 True W000802 Sen. Whitehouse, Sheldon [D-RI] Sheldon Whitehouse D RI 2017-07-11 False K000384 Sen. Kaine, Tim [D-VA] Timothy Kaine D VA M. 2017-11-08 False K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN 2018-03-19 False Crime and Law Enforcement Alternative treatments Child health Drug therapy Drug trafficking and controlled substances Education programs funding Government studies and investigations Health personnel Health programs administration and funding Higher education Licensing and registrations Medical education Medical research Neurological disorders Research administration and funding Trade restrictions Crime and Law Enforcement 00 2017-05-25 Introduced in Senate 2018-01-30T20:38:10Z Cannabidiol Research Expansion Act

This bill requires the Drug Enforcement Administration (DEA) and the Department of Health and Human Services to each evaluate whether cannabidiol, the nonpsychoactive substance derived from marijuana or the synthetic formulation, should be a controlled substance under the Controlled Substances Act. After taking into consideration the evaluations, the DEA must initiate proceedings for classifying cannabidiol as a controlled substance if control is warranted.

The bill expands the authority for: (1) conducting medical research on cannabidiol and other nonpsychoactive components of marijuana, and (2) possessing or transporting cannabidiol or any other nonpsychoactive component of marijuana for certain medicinal purposes.

The Department of Justice shall register an applicant to manufacture or distribute cannabidiol or marijuana for the purpose of commercial production if approved by HHS.

Physicians who are licensed under state law may discuss the potential harms and benefits of cannabidiol or those components of marijuana as a treatment with their patients or the legal guardians of underage patients.

The bill terminates four years after enactment.

]]> Cannabidiol Research Expansion Act Display Title Cannabidiol Research Expansion Act Official Title as Introduced A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marihuana components. Introduced in Senate IS Short Titles as Introduced Cannabidiol Research Expansion Act Introduced in Senate 2017-05-25T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115s1276is/xml/BILLS-115s1276is.xml 2017-05-25 Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S3220-3221) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.